How Long Do You Live After a Hemorrhagic Stroke?

Hemorrhagic stroke carries the highest early death rate of any stroke type, with roughly a third to nearly half of patients dying within 30 days depending on the population studied and the hospital providing care. But that number hides enormous variation. Some people walk out of the hospital within weeks; others never regain consciousness. A large population study from Australia and New Zealand found that hemorrhagic stroke was associated with a loss of about 7.4 years of life expectancy compared with the general population, representing nearly 39% of predicted remaining life. The answer to how long you live after a hemorrhagic stroke depends on a handful of factors that are partly biological, partly medical, and, as growing research reveals, partly about decisions made by the care team in the first hours.

The First 30 Days

The acute period after a hemorrhagic stroke is the most dangerous window. A study of Medicare beneficiaries in the United States found unadjusted 30-day mortality rates of about 40–44% for intracerebral hemorrhage (ICH) and 35–44% for subarachnoid hemorrhage (SAH), with patients treated at certified stroke centers faring better than those at non-certified hospitals.¹ Those numbers reflect an older American population, however. A study from a large Thai referral center reported 30-day mortality rates of about 9% for ICH and 12% for SAH, likely reflecting a younger patient population and aggressive tertiary care.² An older population-based study in the U.S. put 30-day mortality at roughly 44–46% for both ICH and SAH.³

The wide spread across studies is not contradictory. The patient’s age, the severity of the bleed, and where they receive treatment all shift the number dramatically. A 50-year-old with a small, deep brain bleed treated at a high-volume stroke center faces very different odds than an 85-year-old with a large bleed at a community hospital without neurosurgical capability.

What Determines Whether You Survive the Acute Phase

Doctors use a clinical scoring tool called the ICH Score to estimate short-term prognosis after intracerebral hemorrhage. The original validation study identified five independent predictors of 30-day mortality: the patient’s level of consciousness (measured by the Glasgow Coma Scale), age 80 or older, whether the bleed originated in the brainstem or cerebellum, the volume of the blood clot, and whether blood had broken into the brain’s fluid-filled ventricles.⁴ Every patient who scored a zero on this scale survived, and every patient who scored a five died within 30 days. Death rates climbed in a stepwise fashion between those extremes.

The ICH Score and related tools have since been validated across multiple populations and remain widely used.⁵ Researchers have also found that recalculating these scores a few days after the bleed improves their accuracy for predicting six-month mortality, because the brain’s condition several days in reflects the full extent of secondary injury better than the initial scan.⁶

Beyond the ICH Score, comorbidities shape outcomes. Diabetes, kidney disease, and peripheral vascular disease all raise both 30-day and one-year mortality in ICH survivors.⁷ A retrospective study from Ethiopia found that kidney disease roughly tripled the risk of death, and that low consciousness scores and complications like aspiration pneumonia and septic shock also drove mortality higher.⁸

The Self-Fulfilling Prophecy in Early Care

One of the most uncomfortable findings in hemorrhagic stroke research is that early survival statistics are partly shaped by the decisions hospitals make about aggressive treatment. A major study found that withdrawal of life-sustaining treatment significantly mediated the link between impaired consciousness and death. In other words, some patients with reduced consciousness died not purely because their brain injuries were unsurvivable, but because care was withdrawn early.⁹ About half of early withdrawals in that study occurred within two days of admission. After the American Heart Association issued guidelines recommending aggressive treatment and discouraging early do-not-resuscitate orders, the rate of these very early withdrawals declined.

Separately, researchers found that in-hospital mortality after ICH was significantly influenced by the rate at which hospitals used do-not-resuscitate orders, even after accounting for how severe the patients’ strokes were. The variation was not just about individual patient wishes; it reflected broader institutional culture around how aggressively to treat hemorrhagic stroke.¹⁰ This matters for families interpreting survival statistics: a hospital that gives up quickly on hemorrhagic stroke patients will report higher mortality than one that treats aggressively, and neither facility’s numbers tell you what would happen if care were optimized.

Long-Term Survival and Life Expectancy

For those who survive the acute phase, the picture shifts from “will I survive this week” to “how many years do I have.” A large cohort study covering nearly a decade of stroke admissions in Australia and New Zealand found that hemorrhagic stroke was associated with roughly double the long-term mortality risk compared with ischemic stroke. On average, people who had a hemorrhagic stroke lost about 7.4 years of life expectancy, or about 38.5% of their predicted remaining lifespan.¹¹ That figure includes all ages and severities, so the individual loss for a younger, healthier person with a smaller bleed would typically be less.

Among those who survive the initial hospitalization and early recovery, the leading causes of death shift away from the stroke itself. A longitudinal study of ICH survivors found that the top killer was infection, accounting for about a third of all deaths, followed by recurrent brain hemorrhage at 14%, heart disease at 8%, respiratory failure at 8%, and ischemic stroke at 5%.¹² The prominence of infection likely reflects the disability and immobility many survivors live with, which raises the risk of pneumonia and urinary infections. Survivors also continue to face elevated mortality compared with the general population for years afterward, with diabetes and use of blood thinners at the time of the original bleed being independent predictors of later death.⁷

Risk of Having Another Stroke

Surviving one hemorrhagic stroke does not eliminate the risk of having another. A study following ICH survivors found a recurrence rate for a new brain bleed of about 2.1 per 100 patients in the first year, settling to roughly 1.2 per 100 per year over the long term. Those survivors also faced a similar annual rate of ischemic stroke, at about 1.3 per 100 per year.¹³ A larger study from South Korea reported that about 13% of hemorrhagic stroke patients experienced a recurrent stroke of any type within five years, split roughly evenly between new hemorrhages and ischemic strokes.¹⁴

The type of bleed matters for recurrence. A 15-year longitudinal study found that patients whose original hemorrhage was caused by uncontrolled high blood pressure had the highest recurrence rate, with roughly half experiencing a repeat bleed, compared to about a quarter of those whose hemorrhage had other causes.¹⁵ This makes blood pressure control after a hemorrhagic stroke one of the most consequential things a survivor can do.

Blood Pressure Management After the Bleed

In the acute phase, there has been debate over how aggressively to lower blood pressure. A major trial of nearly 2,800 patients with fresh ICH and elevated blood pressure found that intensive lowering to a target of 140 mmHg systolic did not significantly reduce death and disability overall, though it did produce some improvement in functional outcomes on a finer-grained scale.¹⁶

For the longer term, however, the evidence is clearer. A study of ICH survivors found that maintaining a systolic blood pressure between 120 and 129 mmHg at follow-up was associated with the lowest risk of dying, while higher blood pressure levels raised the risk of both recurrent hemorrhage and new ischemic strokes.¹⁷ Given that hypertension-related bleeds had the highest recurrence rate in that 15-year study, this is where prevention has the most room to extend survival.

The Blood Thinner Dilemma

Many hemorrhagic stroke patients were taking blood thinners before their bleed, often because they have atrial fibrillation or a mechanical heart valve. After the hemorrhage, doctors face a difficult tradeoff: stopping the blood thinner protects against another brain bleed but raises the risk of a blood clot causing an ischemic stroke or pulmonary embolism. A review of pooled data found that in the majority of patients, resuming oral anticoagulation after ICH was associated with lower mortality and fewer blood clots without a significantly increased risk of rebleeding.¹⁸

For patients with mechanical heart valves, the timing of restarting is particularly high-stakes. A meta-analysis found that resuming anticoagulation in these patients carried a recurrent brain bleed rate of about 11%, while withholding it led to an ischemic stroke rate of about 6%. There was a suggestion that waiting about 11 days before restarting reduced the rebleed risk.¹⁹ Another systematic review of the same question concluded that pausing anticoagulation for up to seven days appeared relatively safe, though the underlying studies all carried serious bias risks and prospective trials are still needed.²⁰ Every patient’s decision here is individualized, balancing their clotting risk, the location and cause of the bleed, and the type of anticoagulant they need.

Surgery Versus Medical Management

Whether to surgically remove the blood clot from the brain has been one of the most contested questions in hemorrhagic stroke care for decades. A recent meta-analysis found that surgical evacuation was associated with improved functional outcomes and lower overall mortality compared with conservative medical management alone.²¹ A propensity-matched study offered a more nuanced picture: surgery reduced the death rate but also left more survivors with moderate disability rather than full independence, suggesting that surgery saves lives that would otherwise be lost but does not always restore full function.²² That same study found the benefit of minimally invasive surgical approaches was clearest for medium-to-large blood clots.

The practical takeaway is that surgery can extend life, particularly for moderate-sized bleeds in accessible brain locations, but the quality of that extended life varies. Families hearing that surgery is recommended should understand that it often means trading a higher chance of death for a higher chance of surviving with some degree of disability.

Where You Are Treated Makes a Difference

The hospital itself shapes survival odds. As noted earlier, the 30-day mortality rate among Medicare beneficiaries was meaningfully lower at certified stroke centers, with the risk of death dropping by about a third for SAH and about 14% for ICH at those facilities compared with non-certified hospitals.¹ Dedicated stroke units, specifically, have shown benefits that last well beyond the initial hospitalization. A community-based study found that patients treated on a stroke unit had a one-year mortality of 32% versus 39% for those on general wards, and that gap persisted at five years, with stroke unit care independently reducing the risk of death by about 40% after accounting for age, sex, stroke severity, and comorbidities.²³ A separate study reported similar long-term findings, with significantly fewer stroke unit patients dying or ending up in institutional care over follow-up.²⁴

These are not small differences. The benefits of specialized stroke care come from coordinated monitoring, faster response to complications like clot expansion and brain swelling, and structured early rehabilitation. If you have any choice in the matter during the emergency, getting to a hospital with a dedicated stroke unit or neurosurgical capability can meaningfully change the outcome.

Recovery and Functional Outcomes for Survivors

Among those who survive, there is a piece of counterintuitive good news: hemorrhagic stroke survivors often recover functional abilities somewhat better than ischemic stroke survivors. A matched comparison found that hemorrhagic stroke patients had about 2.5 times the odds of achieving a strong recovery response on standard rehabilitation measures compared with ischemic stroke patients.²⁵ This likely reflects the fact that some of the initial damage from a hemorrhagic stroke comes from the pressure of the blood clot and surrounding swelling rather than permanent tissue death, so as these resolve, function can return.

The recovery window is different, though. One study found that hemorrhagic stroke patients showed significant improvement in daily activities up to about 10 weeks after the stroke, while ischemic stroke patients continued to show measurable gains up to 26 weeks.²⁶ The hemorrhagic group recovered faster but plateaued sooner. A separate study looking at postacute rehabilitation outcomes found no significant differences between the two stroke types in overall functioning at discharge, with both groups showing low rates of return to employment (around 22–23% at discharge from rehabilitation).²⁷ Recovery is real, but full return to pre-stroke function is the exception rather than the rule.

Cognitive and Psychological Changes After Hemorrhagic Stroke

Even survivors who regain the ability to walk and take care of themselves often face lasting cognitive changes. An American Heart Association scientific statement on post-stroke cognitive impairment identified brain imaging markers of small vessel disease, including tiny microbleeds in the outer brain regions and overall white matter damage, as important predictors of dementia following hemorrhagic stroke.²⁸ Subarachnoid hemorrhage survivors face their own distinct cognitive trajectory: SAH accounts for only about 5% of all strokes, but survivors experience long-term cognitive decline and an increased risk of developing dementia over the years that follow.²⁹

Memory problems, difficulty concentrating, slowed processing speed, and changes in personality or mood are all common enough that families should plan for them even when physical recovery goes well. Depression after hemorrhagic stroke is widespread and can itself interfere with rehabilitation and long-term survival. These cognitive and emotional changes are often the aspects of survival that families find hardest to adjust to, partly because they are less visible than physical disability and partly because they can emerge or worsen months after the initial event.

Why the Bleed Expands and Why Early Hours Matter So Much

The reason the first hours after a hemorrhagic stroke are so critical has to do with secondary injury. The initial bleed creates a pocket of blood inside the brain, but in many cases that pocket keeps growing. Hematoma expansion, bleeding into the brain’s ventricles, and swelling around the clot can all cause rapid worsening in the acute phase. There can also be a “second peak” of brain swelling days later, driven by inflammation and fluid accumulation around the blood clot.³⁰ This is why patients are monitored intensively for the first several days and why any neurological deterioration during that period is treated as an emergency.

For cerebellar hemorrhages specifically, maintaining adequate blood flow to the brain is critical. Research on patients with spontaneous cerebellar hemorrhage has shown that the amount of time spent with dangerously low brain perfusion pressure during intensive care monitoring is correlated with worse functional outcomes.³¹ The clinical implication is that neurocritical care during this window is not passive observation; it involves active management of brain pressure and blood flow that can genuinely change outcomes.

What Families Should Know About Prognosis Discussions

If there is one thing the research makes clear, it is that early prognoses after hemorrhagic stroke are unreliable and can become self-fulfilling. Scoring tools like the ICH Score do a reasonable job of identifying who is at highest risk, but they were developed in populations where early withdrawal of treatment was common, meaning the deaths they predicted were partly a product of the care decisions they influenced. The finding that hospital-level patterns in do-not-resuscitate orders independently affect mortality means that part of what looks like the natural history of the disease is actually the natural history of how hospitals respond to it.¹⁰

This does not mean every patient should receive maximally aggressive care regardless of circumstances. Some hemorrhagic strokes genuinely are unsurvivable, and palliative care is the compassionate choice when brain damage is catastrophic. But families who are told in the first 24 to 48 hours that survival is unlikely should ask whether that assessment accounts for the potential for secondary injury to stabilize and for prognostic scores to improve over the following days. The research on delayed prognostication scores suggests that waiting a few days before making major treatment decisions improves the accuracy of the prediction.⁶ A 2015 shift in American Heart Association guidelines explicitly recommended against early do-not-resuscitate decisions, and the data suggest that shift led to fewer premature withdrawals of care.⁹

1
PubMed Central. 30-Day Mortality and Readmission after Hemorrhagic Stroke among Medicare Beneficiaries in Joint Commission Primary Stroke Center Certified and Non-Certified Hospitals
2
PubMed. Age as a prognostic factor of 30-day mortality in hemorrhagic stroke patients: A Thai large tertiary care referral center
3
PubMed. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage
4
PubMed. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage
5
PubMed Central. Predicting 30-day mortality in patients with primary intracerebral hemorrhage: Evaluation of the value of intracerebral hemorrhage and modified new intracerebral hemorrhage scores
6
Stroke and Vascular Neurology. Predicting long-term outcomes in acute intracerebral haemorrhage using delayed prognostication scores
7
Austin Journal of Cerebrovascular Disease & Stroke. The Role of Age in Intracerebral Hemorrhage: An Intricate Relationship
8
PubMed Central. Factors Associated With Mortality Among Adult Hemorrhagic Stroke Patients in Public Hospitals in the Harari Region, Eastern Ethiopia
9
PubMed Central. Withdrawal of Life-Sustaining Treatment Mediates Mortality in Patients With Intracerebral Hemorrhage With Impaired Consciousness
10
PubMed. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage
11
PubMed Central. Long-Term Survival, Stroke Recurrence, and Life Expectancy After an Acute Stroke in Australia and New Zealand From 2008-2017
12
PubMed Central. Cause of death in spontaneous intracerebral hemorrhage survivors: Multistate longitudinal study
13
PubMed Central. The risk of recurrent stroke after intracerebral haemorrhage
14
Scientific Reports. Risk factors for stroke recurrence in patients with hemorrhagic stroke
15
PubMed Central. Distinctive mortality patterns and the survival paradox in intracerebral haemorrhage subtypes: a 15-year longitudinal study
16
PubMed Central. Blood Pressure Goals in Acute Stroke
17
PubMed Central. The association of first follow-up blood pressure level with recurrent stroke and mortality in survivors of spontaneous intracerebral hemorrhage
18
PubMed. Between a rock and a hard place: resumption of oral anticoagulant therapy after intracranial hemorrhage
19
PubMed Central. Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients With Mechanical Valves: A Meta-Analysis
20
PubMed Central. Resumption of Warfarin After Intracranial Hemorrhage in Patients With Mechanical Heart Valves: A Systematic Review and Meta‐Analysis
21
PubMed Central. Surgical management of intracerebral hemorrhage: A meta-analysis demonstrating improved functional outcome and survival with time-dependent functional benefit
22
PubMed. Medical versus Surgical Treatment in Acute Intracerebral Hemorrhage: A Propensity-Matched Analysis
23
PubMed. Treatment and rehabilitation on a stroke unit improves 5-year survival. A community-based study
24
PubMed. Stroke unit treatment. Long-term effects
25
PubMed. Functional outcome of ischemic and hemorrhagic stroke patients after inpatient rehabilitation: a matched comparison
26
PubMed. Functional recovery differs between ischaemic and haemorrhagic stroke patients
27
PubMed Central. Rehabilitation Outcomes: Ischemic versus Hemorrhagic Strokes
28
PubMed Central. Cognitive Impairment Following Ischemic and Hemorrhagic Stroke: A Scientific Statement from the American Heart Association/American Stroke Association
29
PubMed. Long-Term Cognitive Decline After Subarachnoid Hemorrhage: Pathophysiology, Management, and Future Directions
30
PubMed Central. Progressing haemorrhagic stroke: categories, causes, mechanisms and managements
31
PubMed Central. Temporal dynamics of ICP, PRx, CPP, and CPPopt in relation to functional outcome in spontaneous cerebellar hemorrhage